title: Examination of the possible mediation of antineoplastic effects of opiates through the inhibition of tyrosine-specific protein kinases.
authors.affiliation: Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
authors.forename: T R
authors.initials: TR
authors.lastname: Burke
authors.forename: Z H
authors.initials: ZH
authors.lastname: Li
authors.forename: J B
authors.initials: JB
authors.lastname: Bolen
authors.forename: M
authors.initials: M
authors.lastname: Chapekar
authors.forename: Y
authors.initials: Y
authors.lastname: Gang
authors.forename: R I
authors.initials: RI
authors.lastname: Glazer
authors.forename: K C
authors.initials: KC
authors.lastname: Rice
authors.forename: V E
authors.initials: VE
authors.lastname: Marquez
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D002460:Cell Line; D066246:ErbB Receptors / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D006873:Hydroquinones / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology*; D010620:Phenazocine / Q000494:pharmacology; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship
chemical_list: D000970:Antineoplastic Agents; D006873:Hydroquinones; D009294:Narcotics; D009020:Morphine; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; D010620:Phenazocine; C048212:erbstatin